Rong-Guang Shao - Search Results

Year	Number of Results
2002	1
2003	2
2004	4
2005	2
2006	1
2007	3
2008	5
2009	6
2010	7
2011	2
2012	6
2013	6
2014	7
2015	8
2016	3
2017	7
2018	4
2019	5
2020	6
2021	2
2022	1
2024	0

1

Mitochondria autophagy: a potential target for cancer therapy.

Qiu YH, Zhang TS, Wang XW, Wang MY, Zhao WX, Zhou HM, Zhang CH, Cai ML, Chen XF, Zhao WL, Shao RG. Qiu YH, et al. Among authors: shao rg. J Drug Target. 2021 Jul;29(6):576-591. doi: 10.1080/1061186X.2020.1867992. Epub 2021 Feb 8. J Drug Target. 2021. PMID: 33554661 Review.

2

Advances in understanding the regulatory mechanism of cholesterol 7α-hydroxylase.

Ge MX, Shao RG, He HW. Ge MX, et al. Among authors: shao rg. Biochem Pharmacol. 2019 Jun;164:152-164. doi: 10.1016/j.bcp.2019.04.008. Epub 2019 Apr 10. Biochem Pharmacol. 2019. PMID: 30978324 Review.

3

Role of co- and post-translational modifications of SFKs in their kinase activation.

Cai ML, Wang MY, Zhang CH, Wang JX, Liu H, He HW, Zhao WL, Xia GM, Shao RG. Cai ML, et al. Among authors: shao rg. J Drug Target. 2020 Jan;28(1):23-32. doi: 10.1080/1061186X.2019.1616297. Epub 2019 Jun 27. J Drug Target. 2020. PMID: 31094236 Review.

4

Role and molecular mechanism of stem cells in colorectal cancer initiation.

Wang MY, Qiu YH, Cai ML, Zhang CH, Wang XW, Liu H, Chen Y, Zhao WL, Liu JB, Shao RG. Wang MY, et al. Among authors: shao rg. J Drug Target. 2020 Jan;28(1):1-10. doi: 10.1080/1061186X.2019.1632317. Epub 2019 Jun 27. J Drug Target. 2020. PMID: 31244351 Review.

5

Recent progression in the utilization of autophagy-regulating nature compound as anti-liver fibrosis agents.

Ge MX, He HW, Shao RG, Liu H. Ge MX, et al. Among authors: shao rg. J Asian Nat Prod Res. 2017 Feb;19(2):109-113. doi: 10.1080/10286020.2016.1276168. Epub 2017 Jan 29. J Asian Nat Prod Res. 2017. PMID: 28133978 Review.

6

Enediyne anticancer antibiotic lidamycin: chemistry, biology and pharmacology.

Shao RG, Zhen YS. Shao RG, et al. Anticancer Agents Med Chem. 2008 Feb;8(2):123-31. doi: 10.2174/187152008783497055. Anticancer Agents Med Chem. 2008. PMID: 18288918 Review.

7

[G3BP: a promising target for cancer therapy].

Zhang H, Shao RG. Zhang H, et al. Among authors: shao rg. Yao Xue Xue Bao. 2010 Aug;45(8):945-51. Yao Xue Xue Bao. 2010. PMID: 21351580 Review. Chinese.

8

Pharmacology and therapeutic applications of enediyne antitumor antibiotics.

Shao RG. Shao RG. Curr Mol Pharmacol. 2008 Jan;1(1):50-60. doi: 10.2174/1874467210801010050. Curr Mol Pharmacol. 2008. PMID: 20021423 Review.

9

Novel N-substituted sophoridinol derivatives as anticancer agents.

Bi CW, Zhang CX, Li YH, Tang S, Deng HB, Zhao WL, Wang Z, Shao RG, Song DQ. Bi CW, et al. Among authors: shao rg. Eur J Med Chem. 2014 Jun 23;81:95-105. doi: 10.1016/j.ejmech.2014.04.069. Epub 2014 May 2. Eur J Med Chem. 2014. PMID: 24826818

10

[Advances in studies of ileal apical sodium-dependent bile acid transporter].

Ge MX, Wang JX, Shao RG, He HW. Ge MX, et al. Among authors: shao rg. Yao Xue Xue Bao. 2017 Feb;52(2):189-97. Yao Xue Xue Bao. 2017. PMID: 29979499 Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

80 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year